Showing results (811-820 of 948) with videos related to

Sort By:
Pageof 95
Journal of Personality Disorders|February 24, 2001
The Collaborative Longitudinal Personality Disorders Study: development, aims, design, and sample characteristicsJ G Gunderson, M T Shea, A E Skodol, et al.
Cancer Cell|May 17, 2005
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formationJonas A Nilsson, Ulrich B Keller, Troy A Baudino, et al.
Pediatrics|January 1, 1987
Is chronic lung disease in low birth weight infants preventable? A survey of eight centersM E Avery, W H Tooley, J B Keller, et al.
The Oncologist|February 24, 2024
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLCPhilip C Mack, Rachel B Keller-Evans, Gerald Li, et al.
The EMBO Journal|April 28, 2007
Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesisUlrich B Keller, Jennifer B Old, Frank C Dorsey, et al.
Carbohydrate Polymers|March 13, 2021
Light-stimulated T. thermophilus two-domain LPMO9H: Low-resolution SAXS model and synergy with cellulasesPaula M R Higasi, Josman A Velasco, Vanessa O A Pellegrini, et al.
Frontiers in Cellular and Infection Microbiology|August 22, 2022
Bactericidal and anti-biofilm effects of uncharged and cationic ultrasound-responsive nitric oxide microbubbles on Pseudomonas aeruginosa biofilmsGareth LuTheryn, Charlotte Hind, Christopher Campbell, et al.
Molecules (Basel, Switzerland)|December 9, 2023
Sonosensitive Cavitation Nuclei-A Customisable Platform Technology for Enhanced Therapeutic DeliveryBrian Lyons, Joel P R Balkaran, Darcy Dunn-Lawless, et al.
The Journal of Clinical Psychiatry|May 25, 2002
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combinationPhilip T Ninan, A John Rush, Paul Crits-Christoph, et al.
Journal of Affective Disorders|June 1, 2010
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended releaseMadhukar H Trivedi, David L Dunner, Susan G Kornstein, et al.
Pageof 95